Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSPC Pharmaceutical
Biotech
AstraZeneca pens $5.3B pact with CSPC to develop oral drugs
AstraZeneca has returned to recent collaborator CSPC with $110 million in upfront cash to find new oral drugs for a range of chronic diseases.
James Waldron
Jun 13, 2025 5:56am
Radiance joins ROR1 race, paying $15M for ADC to challenge Merck
Feb 19, 2025 7:32am
Corbus posts first US data on challenger to Pfizer's ADC Padcev
Feb 14, 2025 9:20am
BeiGene inks $150M deal to follow cancer trail blazed by Amgen
Dec 13, 2024 9:11am
AstraZeneca pays CSPC $100M for preclinical heart disease drug
Oct 7, 2024 6:12am
Tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Feb 13, 2023 10:00am
